Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women-Reference-Cited by-同舟云学术

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

Published:2005-12-02 Issue:3 Volume:97 Page:237-244
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Pentheroudakis George,Fountzilas George,Bafaloukos Dimitrios,Koutsoukou Vasiliki,Pectasides Dimitrios,Skarlos Dimosthenis,Samantas Epaminondas,Kalofonos Haralabos P.,Gogas Helen,Pavlidis Nicholas

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-005-9117-4.pdf

Reference12 articles.

1. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G, 1987 Clinical course of breast cancer patients with liver metastases J Clin Oncol 5: 773–782

2. O`Reilly SM, Richards MA, Rubens RD, 1990 Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival Eur J Cancer 26: 574–577

3. Hoe AL, Royle GT, Taylor I, 1991 Breast liver metastases-incidence, diagnosis and outcome J R Soc Med 84: 714–716

4. Fumoleau P, 1996 Treatment of patients with liver metastases Anticancer Drugs 7(Suppl 2): 21–23

5. Paridaens R, Biganzoli L, Bruning P, et al. 2000 Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a EORTC randomized study with cross-over J Clin Oncol 18: 724–733

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prognostic model for triple-negative breast cancer patients with liver metastasis: A population-based study;Heliyon;2024-04

2. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer;Drug Resistance Updates;2024-03

3. A promising target for breast cancer: B7-H3;BMC Cancer;2024-02-07

4. Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis;Breast Cancer Research and Treatment;2023-12-21

5. The Anti-Cancer Activity of the Naturally Occurring Dipeptide Carnosine: Potential for Breast Cancer;Cells;2023-11-08